These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 82610)

  • 21. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
    Stave JW; Card JL; Morgan DO
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of the immunogenic potencies of purified inactivated foot-and-mouth disease virus particles with variable amounts of VP1 protein (author's transl)].
    Bernard S; Grosclaude J; Adamowicz P; Guerche J
    Ann Rech Vet; 1977; 8(1):79-94. PubMed ID: 195512
    [No Abstract]   [Full Text] [Related]  

  • 24. A mechanism involved in the plaque enhancement effect of sodium thiosulfate for foot-and-mouth disease viruses.
    Kadoi K
    Microbiologica; 1992 Oct; 15(4):399-401. PubMed ID: 1331716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus.
    Parry N; Fox G; Rowlands D; Brown F; Fry E; Acharya R; Logan D; Stuart D
    Nature; 1990 Oct; 347(6293):569-72. PubMed ID: 1699132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative trial of the immunogenic properties of commercial foot-and-mouth virus strains].
    Tekerlekov P; Nikolova E
    Vet Med Nauki; 1981; 18(1):19-26. PubMed ID: 6272473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the antigenic variation within type-A foot and mouth disease virus isolates from Asia.
    Rweyemamu MM; Ouldridge EJ; Head M; Purse F
    J Biol Stand; 1984; 12(2):191-4. PubMed ID: 6203914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four independent antigenic determinants on the capsid polypeptides of aphthovirus.
    Haresnape JM; McCahon D
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2345-55. PubMed ID: 6196438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response against foot and mouth disease virus (FMDV). Part I: Responses measured in sera of vaccinated steers with complete virus, trypsin treated virus, 12 S virus subunits and heterologous virus.
    Meloen RH
    Zentralbl Veterinarmed B; 1979 May; 26(4):273-83. PubMed ID: 225907
    [No Abstract]   [Full Text] [Related]  

  • 30. Nature of the inactivating action of trypsin on foot-and-mouth disease virus.
    Wild TF; Brown F
    J Gen Virol; 1967 Apr; 1(2):247-50. PubMed ID: 4293940
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative studies on growth of foot-and-mouth disease virus types 0 and Asia 1 in BHK-21 Razi cells.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1986 Sep; 30(5):367-72. PubMed ID: 2878583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of monoclonal antibodies to foot-and-mouth disease virus type Asia-1.
    Amineva SP; Davydova NL; Mamatkulova LU; Globenko LA; Mishchenko VA
    Biochemistry (Mosc); 1997 May; 62(5):469-73. PubMed ID: 9275286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Attempts to adapt BNK cells to cultivation in suspension and study of the antigenic properties of foot-and-mouth diseases viruses obtained from them].
    Mitev G; Tekerlekov P; Nikolova E
    Vet Med Nauki; 1976; 13(7):91-5. PubMed ID: 189487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antigenic properties of the foot-and-mouth disease virus concentrated by polyethylene glycol].
    Sobko AI; Prokhorov VN; Sokolov LN; Koshetsian EG
    Veterinariia; 1973 May; 49(5):67-8. PubMed ID: 4353691
    [No Abstract]   [Full Text] [Related]  

  • 35. [Differences in the antigenic structure of strains of the foot-and-mouth disease virus].
    Sobko AI; Koshetsian EG; Kochergina MF; Shevardin AN; Perevozchikov VA
    Veterinariia; 1974 Sep; (9):36-8. PubMed ID: 4143073
    [No Abstract]   [Full Text] [Related]  

  • 36. Biological behaviour & antigenicity of mouse passaged & formol inactivated foot & mouth disease virus type Asia-1 in guineapigs.
    Saraswat KC; Sharma KN; Mehrotra PN
    Indian J Exp Biol; 1980 Mar; 18(3):275-8. PubMed ID: 6248457
    [No Abstract]   [Full Text] [Related]  

  • 37. [The use of synthetic peptides for detection of antibodies against foot-and-mouth disease virus in the blood from convalescent animals].
    Petrov VN; Rybakov SS; Petrova ON; Lugovskoĭ AA; Pavlov AV
    Mol Gen Mikrobiol Virusol; 1996; (3):27-31. PubMed ID: 8999315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent infection of African buffalo (Syncerus caffer) with SAT-type foot-and-mouth disease viruses: rate of fixation of mutations, antigenic change and interspecies transmission.
    Vosloo W; Bastos AD; Kirkbride E; Esterhuysen JJ; van Rensburg DJ; Bengis RG; Keet DW; Thomson GR
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1457-67. PubMed ID: 8757987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primary structure of the gene for protein VP1 from foot-and-mouth disease virus serotype O1 isolated in the USSR].
    Onishchenko AM; Petrov NA; Mamaeva NV; Kalashnikova TI; Grinev AA; Sosnovtsev SV; Degtiarev SKh; Karpyshev NN; Perevozchikova NA; Ivaniushchenkov Vn
    Mol Gen Mikrobiol Virusol; 1990 Apr; (4):22-5. PubMed ID: 1694961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for recombination between two different immunological types of foot-and-mouth disease virus.
    Mackenzie JS; Slade WR
    Aust J Exp Biol Med Sci; 1975 Aug; 53(4):251-6. PubMed ID: 180948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.